Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations

被引:3
|
作者
Bartziokas, Konstantinos [1 ,2 ]
Papathanasiou, Evgenia [2 ]
Papaioannou, Andriana I. I. [2 ]
Papanikolaou, Ilias [3 ]
Antonakis, Emmanouil [3 ]
Makou, Ioanna [3 ]
Hillas, Georgios [4 ]
Karampitsakos, Theodoros [4 ]
Papaioannou, Ourania [4 ]
Dimakou, Katerina [4 ]
Apollonatou, Vasiliki [2 ]
Verykokou, Galateia [2 ]
Papiris, Spyros [2 ]
Bakakos, Petros [5 ]
Loukides, Stelios [2 ]
Kostikas, Konstantinos [1 ]
机构
[1] Univ Ioannina, Resp Med Dept, Ioannina 45110, Greece
[2] Natl & Kapodistrian Univ Athens, Resp Med Dept 2, Athens 10679, Greece
[3] Corfu Gen Hosp, Resp Med Dept, Corfu 49100, Greece
[4] Sotiria Chest Hosp, Resp Med Dept 5, Athens 11527, Greece
[5] Natl & Kapodistrian Univ Athens, Resp Med Dept 1, Athens 10676, Greece
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 04期
关键词
COPD; exacerbations; eosinophils; hospital admission; non-invasive ventilation; OBSTRUCTIVE PULMONARY-DISEASE; HOSPITALIZED EXACERBATIONS; MECHANICAL VENTILATION; BLOOD EOSINOPHILS; INFECTION; OUTCOMES;
D O I
10.3390/jpm13040686
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of adverse outcomes. Objectives: The aim of the present post hoc analysis was to elucidate the effectiveness of blood eosinophils for predicting the need of NIV in subjects with COPD exacerbation. Methods: Consecutive subjects admitted to a hospital for COPD exacerbation were included in the analysis. The eosinophil count from the first complete blood count was used to designate the eosinophil groups. The relationship between the clinical characteristics and blood eosinophil counts, as dichotomized using 150 cells/mu L, was evaluated. Results Subjects with blood eosinophil number < 150 k/mu L had a more severe disease on admission compared to subjects with >= 150 k/mu L, regarding pH 7.400 (7.36, 7.44) vs. 7.42 (7.38, 7.45), p = 0.008, PO2/FiO(2) levels 238.1 (189.8, 278.6) vs. 276.2 (238.2, 305.6), p < 0.001, CRP (mg/L) levels 7.3 (3.1, 19.9) vs. 3.5 (0.7, 7.8), p < 0.001 and required a longer hospital stay (days) 10.0 (8.0, 14.0) vs. 5.0 (3.0, 7.0) p < 0.001 respectively. The number of blood eosinophils correlated with the levels of CRP upon admission (p < 0.001, r = -0.334), with arterial pH upon admission (p < 0.030, r = 0.121), with PO2/FiO(2) (p < 0.001, r = -0.248), and with duration of hospital stay (p < 0.001, r = -0.589). In the multinomial logistic regression analysis, blood eosinophil count < 150 k/mu L was an independent predictor of the use of NIV during hospital stay. Conclusion: During COPD exacerbation, low blood eosinophil levels upon admission are related to more severe disease and can be used as a predictor of the need of NIV. Further prospective studies are needed to identify the use of blood eosinophil levels as a predictor of unfavorable outcomes.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
    Adepoju, Victor A.
    BREATHE, 2019, 15 (04) : 353 - 355
  • [32] Acetazolamide use in severe COPD exacerbations requiring invasive mechanical ventilation: impact on duration of mechanical ventilation
    Bahloul, Mabrouk
    Chtara, Kamilia
    Chelly, Hedi
    Regaieg, Kais
    Chaari, Anis
    Bouaziz, Mounir
    JOURNAL OF THORACIC DISEASE, 2016, 8 (05) : 762 - 764
  • [33] Noninvasive positive pressure ventilation in COPD
    Windisch, W.
    BREATHE, 2011, 8 (02) : 114 - 123
  • [34] URINE BIOMARKER PROFILES ASSOCIATED WITH COPD EXACERBATIONS
    Yousuf, A.
    Parekh, G.
    Watson, L.
    George, L.
    Singapuri, A.
    Mistry, V.
    Davis, P.
    Brightling, C.
    THORAX, 2017, 72 : A182 - A183
  • [35] Serum Procalcitonin as a Biomarker for the Prediction of Bacterial Exacerbation and Mortality in Severe COPD Exacerbations Requiring Mechanical Ventilation
    Ergan, Begum
    Sahin, Ahmet Altay
    Topeli, Arzu
    RESPIRATION, 2016, 91 (04) : 316 - 324
  • [36] Noninvasive ventilation for exacerbations of chronic obstructive pulmonary disease
    Baumel, MJ
    Schwab, RJ
    Collman, RG
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11): : 735 - 736
  • [37] Risk factors of in-hospital mortality and discriminating capacity of NIVO score in exacerbations of COPD requiring noninvasive ventilation
    Zhang, Jiarui
    Yi, Qun
    Zhou, Chen
    Luo, Yuanming
    Wei, Hailong
    Ge, Huiqing
    Liu, Huiguo
    Zhang, Jianchu
    Li, Xianhua
    Xie, Xiufang
    Pan, Pinhua
    Yi, Mengqiu
    Cheng, Lina
    Zhou, Hui
    Liu, Liang
    Aili, Adila
    Liu, Yu
    Peng, Lige
    Pu, Jiaqi
    Zhou, Haixia
    CHRONIC RESPIRATORY DISEASE, 2024, 21
  • [38] Long-term effects of Noninvasive ventilation (NIV) on exacerbations rate and mortality in stable hypercapnic COPD patients
    Fanaridis, M.
    Bouloukaki, I.
    Stathakis, G.
    Vaios, G.
    Voulgaris, A.
    Steiropoulos, P.
    Tzanakis, N.
    Schiza, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [39] Perceptions of Noninvasive Ventilation During Exercise in Noninvasive Ventilation-Naive Patients With COPD
    Dennis, Clancy J.
    Menadue, Collette
    Schneeberger, Tessa
    Leitl, Daniela
    Schoenheit-Kenn, Ursula
    Harmer, Alison R.
    Barnes, David J.
    Koczulla, Andreas R.
    Kenn, Klaus
    Alison, Jennifer A.
    RESPIRATORY CARE, 2022, 67 (05) : 543 - 552
  • [40] Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD
    Coughlin, Steven
    Peyerl, Fred W.
    Munson, Sibyl H.
    Ravindranath, Aditi J.
    Lee-Chiong, Teofilo L., Jr.
    VALUE IN HEALTH, 2017, 20 (03) : 379 - 387